Finalist
INSPIRE: Improving Outcomes in Paediatric Cardiology
Summary of work
Babies with congenital heart disease (CHD) present a wide range of anatomical abnormalities; uniting the diverse pathology is a risk of life-threatening complications and a paucity of research and investment. Without big funding, there are few multinational trials and international congresses that generate robust data and showcase results: there is limited infrastructure to enable paediatric cardiologists across the world to connect. This lack of connection hampers collaborative research, and honest expertise and experience sharing, impeding advances in quality of care.
INSPIRE was established to drive implementation of a core set of clinical behaviours underpinning optimal clinical management of babies with CHD. INSPIRE (International Specialist Paediatric Cardiology Care) mapped key components and behaviours that contribute to optimal care and worked with global leaders to develop small-group, practical, in-clinic training blending traditional medical education and peer-to-peer sharing in an open, honest and safe environment. A flexible approach addressed variations in global clinic models/challenges and a tailored agenda addressed delegates’ barriers. Four months later, 100% of delegates were using INSPIRE learnings to inform their clinical practice with 82% noting advances to their clinical management strategies aligned to the core behaviours. Together INSPIRE has helped up to 7,700 vulnerable paediatric patients per year receive improved care.
Judges’ comments
The objectives from AbbVie and Lucid were well thought through. There was a very clear strategy and great feedback from participants. There was evidence of deep market and customer insight, as well as proof of improved health outcomes. The patient outcomes showed good, proper benefits, with 7,700 patients receiving approved care.
